{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:52:25Z","timestamp":1760298745821},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1097\/mjt.0b013e31828fdaed","type":"journal-article","created":{"date-parts":[[2013,6,19]],"date-time":"2013-06-19T12:22:57Z","timestamp":1371644577000},"page":"e225-e228","source":"Crossref","is-referenced-by-count":14,"title":["Levetiracetam"],"prefix":"10.1097","volume":"21","author":[{"given":"Eileen S.","family":"Hwang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura A.","family":"Siemianowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanchita","family":"Sen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ritesh","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-30-20210202","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.3171\/FOC.2008.25.10.E3","article-title":". Levetiracetam versus phenytoin for seizure prophylaxis in severe traumatic brain injury.","volume":"25","author":"Jones","year":"2008","journal-title":"Neurosurg Focus"},{"key":"R3-30-20210202","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.wneu.2010.09.002","article-title":". Comparison of short-duration levetiracetam with extended-course phenytoin for seizure prophylaxis after subarachnoid hemorrhage.","volume":"75","author":"Murphy-Human","year":"2011","journal-title":"World Neurosurg"},{"key":"R4-30-20210202","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s12028-009-9304-y","article-title":". Prospective, randomized, single-blinded comparative trial of intravenous levetiracetam versus phenytoin for seizure prophylaxis.","volume":"12","author":"Szaflarski","year":"2010","journal-title":"Neurocrit Care"},{"key":"R5-30-20210202","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1471-2377-12-30","article-title":". Phenytoin versus levetiracetam for seizure prophylaxis after brain injurya meta analysis.","volume":"12","author":"Zafar","year":"2012","journal-title":"BMC Neurol"},{"key":"R6-30-20210202","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1001\/archneurol.2012.445","article-title":". Results of phase 2 safety and feasibility study of treatment with levetiracetam for prevention of posttraumatic epilepsy.","volume":"69","author":"Klein","year":"2012","journal-title":"Arch Neurol"},{"key":"R7-30-20210202","first-page":"1","article-title":". Practice guideline for the treatment of patients with delirium. American Psychiatric Association.","volume":"156","author":"Trzepacz","year":"1999","journal-title":"Am J Psychiatry"},{"key":"R8-30-20210202","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1046\/j.1525-1497.1998.00073.x","article-title":". Does delirium contribute to poor hospital outcomes A three-site epidemiologic study.","volume":"13","author":"Inouye","year":"1998","journal-title":"J Gen Intern Med"},{"key":"R9-30-20210202","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/0891988706286509","article-title":". Delirium in older patients admitted to general internal medicine.","volume":"19","author":"Edlund","year":"2006","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"R10-30-20210202","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.mcna.2011.02.005","article-title":"The evaluation and management of delirium among older persons.","volume":"25","author":"Flaherty","year":"2011","journal-title":"Med Clin North Am"},{"key":"R11-30-20210202","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1136\/bmj.39169.706574.AD","article-title":"Delirium in older people.","volume":"334","author":"Young","year":"2007","journal-title":"BMJ"},{"key":"R12-30-20210202","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1528-1167.2012.03563.x","article-title":". Tolerability, safety, and side effects of levetiracetam versus phenytoin in intravenous and total prophylactic regimen among craniotomy patients: a prospective randomized study.","volume":"54","author":"Fuller","year":"2013","journal-title":"Epilepsia"},{"key":"R13-30-20210202","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.eplepsyres.2007.06.002","article-title":". The SKATE study: an open-label community-based study of levetiracetam as add-on therapy for adults with uncontrolled partial epilepsy.","volume":"76","author":"Steinhoff","year":"2007","journal-title":"Epilepsy Res"},{"key":"R14-30-20210202","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.amjopharm.2010.03.001","article-title":"Separate episodes of delirium associated with levetiracetam and amiodarone treatment in an elderly woman.","volume":"8","author":"Foley","year":"2010","journal-title":"Am J Geriatr Pharmacother"},{"key":"R15-30-20210202","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1532-5415.2011.03749.x","article-title":"A case of physical and mental adverse drug reactions associated with levetiracetam in post-stroke epilepsy.","volume":"60","author":"Robins","year":"2012","journal-title":"J Am Geriatr Soc"},{"key":"R16-30-20210202","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1046\/j.1528-1157.2001.32101.x","article-title":". Levetiracetam psychosis in children with epilepsy.","volume":"42","author":"Kossoff","year":"2001","journal-title":"Epilepsia"},{"key":"R17-30-20210202","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1177\/070674370404901222","article-title":". Drug-induced psychosis after long-term treatment with levetiracetam.","volume":"49","author":"Bayerlein","year":"2004","journal-title":"Can J Psychiatry"},{"key":"R18-30-20210202","first-page":"117","article-title":". Acute psychosis associated with levetiracetam.","volume":"5","author":"Youroukos","year":"2003","journal-title":"Epileptic Disord"},{"key":"R19-30-20210202","doi-asserted-by":"crossref","first-page":"E19","DOI":"10.1176\/jnp.23.3.jnpe19","article-title":"Probable psychosis associated with levetiracetam: a case report.","volume":"22","author":"Aggarwal","year":"2011","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"R20-30-20210202","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.yebeh.2003.07.008","article-title":". Aggressive behavior of epilepsy patients in the course of levetiracetam add-on therapy: report of 33 mild to severe cases.","volume":"4","author":"Dinkelacker","year":"2003","journal-title":"Epilepsy Behav"},{"key":"R21-30-20210202","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":". A method for estimating the probability of adverse drug reactions.","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"}],"container-title":["American Journal of Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MJT.0b013e31828fdaed","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:37:54Z","timestamp":1620963474000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00045391-201411000-00030"}},"subtitle":["An Unusual Cause of Delirium"],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/mjt.0b013e31828fdaed","relation":{},"ISSN":["1075-2765"],"issn-type":[{"value":"1075-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]}}}